 Home > Active Ingredient News > Infection > NEJM: BNT162b2 and mRNA-1273 vaccines can effectively prevent the occurrence of symptomatic new coronary pneumonia infections in healthcare population

NEJM: BNT162b2 and mRNA-1273 vaccines can effectively prevent the occurrence of symptomatic new coronary pneumonia infections in healthcare population

 Last Update: 2021-10-09
 Source: Internet
 Author: User

Tags

doxycycline pneumonia

health benefits dates

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Medical staff are fighting at the forefront of the fight against new coronary pneumonia and are the first group of people who need to be vaccinated against new coronary pneumonia
.
In December 2020, the FDA urgently approved the application of two mRNA vaccines (BNT162b2 and mRNA-1273).

By March 2021, more than half of the first-line medical staff in the United States had received the new coronary pneumonia vaccine

Researchers from the New Coronary Pneumonia FDA recently examined the effectiveness of mRNA vaccines among front-line medical staff

This study is a case-control study involving health care workers in 25 states in the United States

The study included 1482 cases and 3449 control participants
.
After completing part of the vaccination, the effectiveness of the vaccine is as follows: BNT162b2 vaccine (Pfizer-BioNTech) is 77.

6%, and mRNA-1273 vaccine (Moderna) is 88.

The study included 1482 cases and 3449 control participants

Changes in the risk of infection of health care workers after vaccination

After vaccinating health care workers infected with the risk of changes in health care workers vaccinated after infection risk of changes in infection

In a real hospital environment, the BNT162b2 and mRNA-1273 vaccines are very effective in preventing symptomatic Covid-19 infections among medical staff

In a real hospital environment, the BNT162b2 and mRNA-1273 vaccines are very effective in preventing symptomatic Covid-19 infection among medical staff.

Original source:

Tamara Pilishvili et al.

Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel.
Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

2-Mercaptobenzimidazole

CAS No.: 583-39-1

pharmaceutical grade

$100/KG FOB

Factory price Acetic acid 99.8% CAS NO. 64-19-7

CAS No.: 64-19-7

Industrial Grade

$200-250/MT FOB

100% Safe customs clearance high quality Sulfamethazine/Sulphadimidine CAS 57-68-1 with Best Price Sulfamethazine/Sulphadimidine

CAS No.: 57-68-1

Pharmacy Grade

$4-5/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.